The use of an integrated opioid and medical marijuana prescription drug monitoring program

• Main Authors: Karim-Nejad, L. (Author), Rickles, N.M (Author), Wakai, S. (Author)
• Format: Article
• Language: English
• Published: Elsevier B.V. 2021
• Subjects: adult; African American; Analgesics, Opioid; Article; Asian; Asian American; Caucasian; Connecticut; controlled study; cross-sectional study; drug information; drug use; female; Hispanic; human; Humans; major clinical study; male; medical cannabis; Medical Marijuana; naloxone; narcotic analgesic agent; Native Hawaiian; opiate addiction; Opioid-Related Disorders; Pacific Islander; patient care; patient counseling; patient referral; pharmacist; pharmacist attitude; Pharmacists; pharmacy (shop); prescription drug monitoring program; Prescription Drug Monitoring Programs
• Online Access: View Fulltext in Publisher

 Objectives: To (1) identify the reasons for which pharmacists in Connecticut use the CPMRS when dispensing opioid medications and medical marijuana products, (2) determine pharmacists’ perceived value of the CPMRS when dispensing opioids or medical marijuana, and (3) compare practices and the perceived value of the CPMRS among community-based pharmacists (CBPs) and medical marijuana dispensary pharmacists (MMDPs). Methods: An online survey was administered from May 2019 to June 2019 to CBPs (n = 178) and MMDPs (n = 12). The survey included items about background, use, and attitudes about current and future use of the CPMRS. Results: Both pharmacist groups indicated that opioid use information was the most useful aspect of the CPMRS. Ninety percent of both groups checked patients’ use of opioids using the CPMRS, and 81.2% of the MMDPs compared with 38.4% of the CBPs indicated that they checked for patients’ use of medical marijuana. A greater percentage of MMDPs than CBPs felt that access to the marijuana use information was useful and needed for counseling. Several pharmacists recommended improvements in marijuana use information in the CPMRS and greater efficiencies for users of the system. Conclusion: Access to both marijuana and opioid use information can allow pharmacists to make specific recommendations on the basis of potential drug interactions and dose adjustments. The results from the present study highlight how integrated systems of opioid and marijuana dispensing information can be further enhanced by resolving existing pharmacy barriers involving technology, workflow, and need for systems with more detailed marijuana product information. © 2021 American Pharmacists Association®